Реваскуляризация миокарда при многососудистом атеросклеротическом поражении коронарного русла

Автор: Калугина Лидия Сергеевна, Урванцева И.А.

Журнал: Патология кровообращения и кардиохирургия @journal-meshalkin

Статья в выпуске: 3 т.20, 2016 года.

Бесплатный доступ

Обзор посвящен актуальной проблеме коронарной хирургии - реваскуляризации при многососудистом поражении. Рассмотрены результаты ретроспективных и проспективных исследований эффективности и безопасности различных видов коронарной хирургии. Проанализированы данные современной литературы относительно объема оперативного вмешательства, возможности ликвидации и профилактики рестеноза в просвете стента.

Ишемическая болезнь сердца, реваскуляризация миокарда, эндоваскулярная хирургия, многососудистое поражение коронарного русла

Короткий адрес: https://sciup.org/142140753

IDR: 142140753 | DOI: 10.21688-1681

Список литературы Реваскуляризация миокарда при многососудистом атеросклеротическом поражении коронарного русла

Danchin N., Angioi M., Rodriguez R. Angioplasty in chronic coronary occlusion//Arch mal Coeur Vaiss. 1999. Vol. 99 (suppl. 11). P. 1657-1660.
Meier B., Luethy P., Finci L., Steffenino G.D., Rutishauser W. Coronary wedge pressure in relation to spontaneously visible and recruitable collaterals//Circulation. 2008. Vol. 75. No. 5. P. 906-913.
Safley D.M., House J.A., Marso S.P., Grantham J.A., Rutherford B.D. Improvement in survival following successful percutaneous coronary intervention of coronary chronic total occlusions: variability by target vessel//JACC Cardiovasc. Interv. 2008. Vol. 1. No. 3. P. 295-302 DOI: 10.1016/j.jcin.2008.05.004
Бабунашвили А.М., Иванов В.А. Хронические окклюзии коронарных артерий: анатомия, патофизиология, эндоваскулярное лечение. М: АСВ, 2012. 90 c.
Prasad A., Rihal C.S., Lennon R.J., Wiste H.J., Singh M., Holmes D.R. Jr. Trends in outcomes after percutaneous coronary intervention for chronic total occlusions: a 25-year experience from the Mayo Clinic//J. Am. Coll. Cardiol. 2007. Vol. 49. No. 15. P. 1611-1618.
King S.B. 3rd, Kosinski A.S., Guyton R.A., Lembo N.J., Weintraub W.S. Eight-year mortality in the Emory Angioplasty versus Surgery Trial (EAST)//J. Am. Coll. Cardiol. 2000. Vol. 35. No. 5. P. 1116-1121.
Hlatky M.A., Rogers WJ, Johnstone I., Boothroyd D., Brooks M.M., Pitt B., Reeder G., Ryan T., Smith H., Whitlow P., Wiens R., Mark D.B., Rosen A.D., Detre K., Frye R.L., for the Bypass Angioplasty Revascularization Investigation (BARI) Investigators. Medical care costs and quality of life after randomization to coronary angioplasty or coronary bypass surgery//N. Engl. J. Med. 1997. Vol. 336. No. 2. P. 92-99 DOI: 10.1056/NEJM199701093360203
Detre K.M., Lombardero M.S., Brooks M.M., Hardison R.M., Holubkov R., Sopko G., Frye R.L., Chaitman B.R. The effect of previous coronary-artery bypass surgery on the prognosis of patients with diabetes who have acute myocardial infarction. Bypass Angioplasty Revascularization Investigation Investigators//N. Engl. J. Med. 2000. Vol. 342. No. 14. P. 989-997 DOI: 10.1056/NEJM200004063421401
Booth J., Clayton T., Pepper J., Nugara F., Flather M., Sigwart U., Stables R.H., SoS Investigators. Randomized, controlled trial of coronary artery bypass surgery versus percutaneous coronary intervention in patients with multivessel coronary artery disease: six-year follow-up from the Stent or Surgery Trial (SoS)//Circulation. 2008. Vol. 118. No. 4. P. 381-388. DOI: 10.1161/CirculationAHA.107.739144
Serruys P.W., Morice M.C., Kappetein A.P., Colombo A., Holmes D.R., Mack M.J., Stahle E., Feldman T.E., van den Brand M., Bass E.J., Van Dyck N., Leadley K., Dawkins K.D., Mohr F.W.; SYNTAX Investigators. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease//N. Engl. J. Med. 2009. Vol. 360. No. 10. P. 961-972 DOI: 10.1056/NEJMoa0804626
Mohr F.W., Morice M.C., Kappetein A.P., Feldman T.E., Stahle E., Colombo A., Mack M.J., Holmes D.R. Jr., Morel M.A., Van Dyck N., Houle V.M., Dawkins K.D., Serruys P.W. Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial//Lancet. 2013. Vol. 381. No. 9867. P. 629-638 DOI: 10.1016/S0140-6736(13)60141-5
Hueb W., Lopes N., Gersh B.J., Soares P.R., Ribeiro E.E., Pereira A.C., Favarato D., Rocha A.S., Hueb A.C., Ramires J.A. Ten-year follow-up survival of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease//Circulation. 2010. Vol. 122. No. 10. P. 949-957 DOI: 10.1161/CIRCULATIONAHA.109.911669
Takagi H., Yamamoto H., Iwata K., Goto S.N., Umemoto T.; ALICE (All-Literature Investigation of Cardiovascular Evidence) Group. Drug-eluting stents increase late mortality compared with coronary artery bypass grafting in triple-vessel disease: a meta-analysis of randomized controlled and risk-adjusted observational studies//Int. J. Cardiol. 2012. Vol. 159. No. 3. P. 230-233 DOI: 10.1016/j.ijcard.2012.05.046
Wijns W., Kolh P., Danchin N. et al. Guidelines on myocardial revascularization//Eur. Heart J. 2010. Vol. 31. No. 20. P. 2501-2555 DOI: 10.1093/eurheartj/ehq277
Hillis L.D., Smith P.K., Anderson J.L. et al. 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Developed in collaboration with the American Association for Thoracic Surgery, Society of Cardiovascular Anesthesiologists, and Society of Thoracic Surgeons//J. Am. Coll. Cardiol. 2011. Vol. 58. No. 24. P. e123-210 DOI: 10.1016/j.jacc.2011.08.009
Coronary Revascularization Writing Group, Patel M.R., Dehmer G.J., Hirshfeld J.W. et al. ACCF/SCAI/STS/AATS/AHA/ASNC/HFSA/SCCT 2012 appropriate use criteria for coronary revascularization focused update: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, American Association for Thoracic Surgery, American Heart Association, American Society of Nuclear Cardiology, and the Society of Cardiovascular Computed Tomography//J. Thorac. Cardiovasc. Surg. 2012. Vol. 143. No. 4. P. 780-803. DOI: 10.1016/j. jtcvs.2012.01.061
Corpus R.A., House J.A., Marso S.P., Grantham J.A., Huber K.C. Jr., Laster S.B., Johnson W.L., Daniels W.C., Barth C.W., Giorgi L.V., Rutherford B.D. Multivessel percutaneous coronary intervention in patients with multivessel disease and acute myocardial infarction//Am. Heart J. 2004. Vol. 148. No. 3. P. 493-500. DOI: 10.1016/j. ahj.2004.03.051
Meliga E., Fiorina C., Valgimigli M., Belli R., Gagnor A., Sheiban I., Resmini C., Tizzani E., Aranzulla T., Scrocca I., DE Benedictis M., Conte M.R. Early angio-guided complete revascularization versus culprit vessel PCI followed by ischemia-guided staged PCI in STEMI patients with multivessel disease//J. Interv. Cardiol. 2011. Vol. 24. No. 6. P. 535-541 DOI: 10.1111/j.1540-8183.2011.00666.x
Vlaar P.J., Mahmoud K.D., Holmes D.R. Jr., van Valkenhoef G., Hillege H.L., van der Horst I.C., Zijlstra F., de Smet B.J. Culprit vessel only versus multivessel and staged percutaneous coronary intervention for multivessel disease in patients presenting with ST-segment elevation myocardial infarction: a pairwise and network meta-analysis//J. Am. Coll. Cardiol. 2011. Vol. 58. No. 7. P. 692-703 DOI: 10.1016/j.jacc.2011.03.046
Politi L., Sgura F., Rossi R., Monopoli D., Guerri E., Leuzzi C., Bursi F., Sangiorgi G.M., Modena M.G. A randomised trial of target-vessel versus multi-vessel revascularisation in ST-elevation myocardial infarction: major adverse cardiac events during long-term follow-up//Heart. 2010. Vol. 96. No. 9. P. 662-667. DOI: 10.1136/hrt.2009.177162
Hannan E.L., Samadashvili Z., Walford G. Culprit vessel percutaneous coronary intervention versus multivessel and staged percutaneous coronary intervention for ST-segment elevation myocardial infarction patients with multivessel disease//JACC Cardiovasc. Interv. 2010. Vol. 3. No. 1. P. 22-31 DOI: 10.1016/j.jcin.2009.10.017
Bosch X., Marrugat J., Sanchis J. Platelet glycoprotein IIb/IIIa blockers during percutaneous coronary intervention and as the initial medical treatment of non-ST segment elevation acute coronary syndromes//Cochrane Database Syst. Rev. 2013. (11): CD002130 DOI: 10.1002/14651858.CD002130.pub4
Xu X., Zhang W., Zhou Y., Zhao Y., Liu Y., Shi D., Zhou Z., Ma H., Wang Z., Yu M., Ma Q., Gao F., Shen H., Zhang J. Effect of trimetazidine on recurrent angina pectoris and left ventricular structure in elderly multivessel coronary heart disease patients with diabetes mellitus after drug-eluting stent implantation: a single-centre, prospective, randomized, double-blind study at 2-year follow-up//Clin. Drug Investig. 2014. Vol. 34. No. 4. P. 251-258. DOI: 10.1007/s40261-014-0170-9
Wohrle J., Krause B.J., Nusser T., Kochs M., Hoher M. Repeat intracoronary beta-brachytherapy using a rhenium-188-filled balloon catheter for recurrent restenosis in patients who failed intracoronary radiation therapy//Cardiovasc. Revasc. Med. 2006. Vol. 7. No. 1. P. 2-6 DOI: 10.1016/j.carrev.2005.12.005
Eisenberg M.J., Konnyu K.J. Review of randomized clinical trials of drug-eluting stents for the prevention of in-stent restenosis//Am. J. Cardiol. 2006. Vol. 98. No. 3. P. 375-382. DOI: 10.1016/j. amjcard.2006.02.042
Akin I., Schneider H., Ince H., Kische S., Rehders T.C., Chatterjee T., Nienaber C.A. Second-and third-generation drug-eluting coronary stents: progress and safety//Herz. 2011. Vol. 36. No. 3. P. 190-196 DOI: 10.1007/s00059-011-3458-z
Калугина Л.С., Урванцева И.А. Реваскуляризация миокарда при многососудистом поражении коронарного русла в сочетании с хронической окклюзией. Выбор тактики//Атеросклероз. 2015. Т. 11. № 4. С. 74-82.

Еще

Статья научная